Synthesis, Crystal Structure and Antitumor Activity of 4-(5-(2,6-Difluorophenyl)-1,3,4-oxadiazol-2-ylthio)-2-(trifluoromethyl)thieno[2,3-d]pyrimidine
Song Xin-Jian,Li Chen-Chen,Wang Xu-Mei,Sun Qi,Yang Ping
DOI: https://doi.org/10.14102/j.cnki.0254-5861.2011-2437
IF: 0.847
2019-01-01
Chinese journal of structural chemistry
Abstract:The title compound 4-(5-(2,6-difluorophenyl)-1,3,4-oxadiazol-2-ylthio)-2-(trifluoromethyl)thieno[2,3-d]pyrimidine (C15H5F5N4OS2, M-r = 416.35) was designed and synthesized as antitumor agent, and its structure was determined by H-1 NMR, C-13 NMR, MS, elemental analysis and single -crystal X-ray diffraction. The crystal belongs to monoclinic system, space group P21/c with a = 9.904(2), b = 10.057(2), c = 16.595(3) angstrom, beta = 100.000(3)degrees, V = 1627.9(6) angstrom(3), Z = 4, F(000) = 832, D-c = 1.699 g/cm(3), mu = 0.395 mm(-1), R = 0.0468 and wR = 0.1255 for 4726 independent reflections (R-int = 0.0336) and 2847 observed ones (I > 2 sigma(I)). The in vitro antitumor activity of the title compound was preliminarily evaluated by the standard MTT assay.